Home
>
National Drug Code (NDC)
>
Triple Antibiotic
Triple Antibiotic - 0168-0012-31 - (Neomycin and Polymyxin B Sulfates and Bacitracin Zinc)
Drug Information of Triple Antibiotic
| Product NDC: | 0168-0012 |
| Proprietary Name: | Triple Antibiotic |
| Non Proprietary Name: | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Active Ingredient(s): | 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g & nbsp; Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Triple Antibiotic
| Product NDC: | 0168-0012 |
| Labeler Name: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100106 |
Package Information of Triple Antibiotic
| Package NDC: | 0168-0012-31 |
| Package Description: | 1 TUBE in 1 CARTON (0168-0012-31) > 28.35 g in 1 TUBE |
NDC Information of Triple Antibiotic
| NDC Code | 0168-0012-31 |
| Proprietary Name | Triple Antibiotic |
| Package Description | 1 TUBE in 1 CARTON (0168-0012-31) > 28.35 g in 1 TUBE |
| Product NDC | 0168-0012 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20100106 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 3.5; 5000 |
| Strength Unit | [USP'U]/g; mg/g; [USP'U]/g |
| Pharmaceutical Classes |
